Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose ilaprazole dual therapy vs vonoprazan dual therapy for Helicobacter pylori eradication
ChiCTR2500095142Phase 4Not yet recruiting
- Sponsor
- Southern Medical University Shenzhen Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ilaprazole, vonoprazan and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Southern Medical University Shenzhen Hospital. Primary endpoint: H. pylori eradication rate. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
ilaprazolevonoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500095142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095142.